Bluejay Diagnostics (BJDX) Current Assets (2022 - 2023)
Bluejay Diagnostics (BJDX) has disclosed Current Assets for 2 consecutive years, with $6.5 million as the latest value for Q3 2023.
- Quarterly Current Assets fell 53.16% to $6.5 million in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $6.5 million through Sep 2023, down 53.16% year-over-year, with the annual reading at $11.8 million for FY2022, N/A changed from the prior year.
- Current Assets hit $6.5 million in Q3 2023 for Bluejay Diagnostics, down from $6.6 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $19.3 million in Q1 2022 to a low of $6.5 million in Q3 2023.